BEAM
Beam Therapeutics Inc.
+1.78 (+7.71%)24.88USD1.2M成交股數2.6B市值–本益比(近四季)16.5股價營收比-94.2%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 490K-94% | 31.7M+325% | 114M+700% | 9.7M-18% | 8.5M+14% | 7.5M-98% | 14.3M-17% | 11.8M-41% | 7.4M | 316M | 17.2M | 20.1M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 95.1M | 105M | 99.3M | 110M | 102M | 98.8M | 94.3M | 87.0M | 84.8M | 140M | 100M | 97.6M |
| 銷售管理費用 | 31.9M | 34.4M | 32.3M | 26.7M | 26.9M | 27.9M | 26.5M | 29.6M | 26.7M | 43.3M | 25.4M | 24.7M |
| 營業利益 | −127M+5% | −107M-10% | −17.4M-84% | −127M+21% | −120M+15% | −119M-190% | −107M-2% | −105M+3% | −104M | 133M | −108M | −102M |
| 營業利益率 | -25,827.1% | -337.8% | -15.3% | -1,307.6% | -1,419.2% | -1,596.9% | -746.4% | -891.1% | -1,405.3% | 42.0% | -629.7% | -507.8% |
| 稅後淨利 | −123M+20% | −94.3M-13% | 243M-352% | −113M+24% | −102M+4% | −108M-176% | −96.7M+1% | −91.1M+10% | −98.7M | 143M | −96.1M | −82.8M |
| 淨利率 | -25,036.3% | -297.2% | 213.1% | -1,162.4% | -1,206.4% | -1,450.2% | -677.5% | -773.5% | -1,331.6% | 45.2% | -558.9% | -411.5% |
| 稀釋 EPS | -1.18+18% | -0.91-26% | 2.52-315% | -1.10-1% | -1.00-17% | -1.23-164% | -1.17-4% | -1.11+3% | -1.21 | 1.91 | -1.22 | -1.08 |
| 稀釋股數 | 104M | 103M | 98.9M | 103M | 102M | 88.0M | 82.4M | 82.3M | 81.7M | 77.2M | 79.0M | 76.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 220M | 288M | 295M | 268M | 282M | 528M | 230M | 293M | 288M | 436M | 169M | 226M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.4B | 1.5B | 1.5B | 1.3B | 1.4B | 1.5B | 1.2B | 1.3B | 1.4B | 1.5B | 1.3B | 1.4B |
| 有息負債 | 100M | 100M | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 319M | 316M | 243M | 345M | 344M | 344M | 380M | 407M | 446M | 478M | 512M | 542M |
| 股東權益 | 1.1B | 1.2B | 1.2B | 966M | 1.1B | 1.1B | 791M | 854M | 913M | 981M | 779M | 812M |
| 負債比 | 23.0% | 21.4% | 16.4% | 26.3% | 24.8% | 23.4% | 32.4% | 32.3% | 32.8% | 32.8% | 39.6% | 40.1% |
| 淨現金(現金 − 有息負債) | 120M | 188M | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −129M+24% | – | – | – | −104M | – | – | −99.7M | – | – | – |
| 資本支出 | – | 2.2M | – | – | – | 3.1M | – | – | 2.4M | – | – | – |
| 自由現金流 | – | −131M+22% | – | – | – | −107M | – | – | −102M | – | – | – |
| 折舊攤銷 | 5.4M | 5.6M | 5.7M | 5.6M | 5.5M | 5.5M | 5.5M | 5.6M | 5.4M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -412.0% | – | – | – | -1,431.7% | – | – | -1,379.0% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 140M | +120.0% | −80.0M | -57.2% | -0.81 | −360M |
| FY2024 | 63.5M | -83.2% | −377M | -593.1% | -4.58 | −356M |
| FY2023 | 378M | +520.0% | −133M | -35.1% | -1.72 | −183M |
| FY2022 | 60.9M | +17.5% | −289M | -474.5% | -4.13 | −26.4M |
| FY2021 | 51.8M | +215916.7% | −371M | -715.0% | -5.77 | −113M |
| FY2020 | 24K | +33.3% | −195M | -810,800.0% | -4.19 | −112M |
| FY2019 | 18K | – | −78.3M | -435,144.4% | -14.05 | −84.5M |